MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.lfs.2026.124725

Медицинская библиотека · Life sciences · 2026

Combined erythropoietin and sodium butyrate ameliorate imiquimod-induced lupus-like autoimmunity in mice through modulation of inflammatory and interferon-associated responses.

Othman Qamar, El-Bahouty Waleed Barakat, Abou El-Seoud Samia H, Kamel Nehal K H, Fayez Mahmoud F A

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Systemic lupus erythematosus (SLE) is a complex autoimmune disorder characterized by systemic inflammation and multi-organ damage. Current therapeutic options remain limited and are associated with significant side effects. This study investigated the immunomodulatory and anti-inflammatory effects of Erythropoietin (EPO) and sodium butyrate (NaB), as individual and combined interventions, in a Balb/C mice model of imiquimod (IMQ)-induced lupus-like autoimmunity.

METHODS

Fifty female Balb/C mice were randomly assigned into five equal groups: normal control, IMQ-untreated SLE, EPO-treated, NaB-treated, and EPO + NaB-treated SLE group. We evaluated the systemic response via body weight changes and splenic index. Immunological and biochemical profiles were assessed through anti-dsDNA antibodies, creatinine levels, and proteinuria. To elucidate the underlying mechanism, we analyzed renal Myxovirus resistance protein 1 (MX1) gene expression (an interferon-regulated marker), interleukin-6 (IL-6) levels, and the immunohistochemical expression of nuclear factor-κB (NF-κB). Histopathological changes in skin and kidney tissues were examined using hematoxylin and eosin (H&E) and Periodic acid-Schiff (PAS) staining.

RESULTS

Combined treatment demonstrated superior efficacy compared to monotherapies. These effects were associated with significant amelioration in body weight, reduction in the splenic index, reduced MX1 expression, and NF-κB suppression, leading to a marked decrease in IL-6, anti-dsDNA antibodies, and creatinine levels. Histopathological analysis confirmed that the combination therapy effectively preserved renal architecture and attenuated skin lesions.

CONCLUSION

EPO and NaB may exert a potent protective effect against SLE-induced damage. These effects were associated with modulation of inflammatory and interferon-associated responses.

Для цитирования: Othman Qamar, El-Bahouty Waleed Barakat, Abou El-Seoud Samia H, Kamel Nehal K H, Fayez Mahmoud F A. Combined erythropoietin and sodium butyrate ameliorate imiquimod-induced lupus-like autoimmunity in mice through modulation of inflammatory and interferon-associated responses.. Life sciences. 2026. DOI: 10.1016/j.lfs.2026.124725.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.